Literature DB >> 27012775

Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations.

Justin A Fletcher1, Melissa A Linden1, Ryan D Sheldon1, Grace M Meers2, E Matthew Morris3, Anthony Butterfield4, James W Perfield4, John P Thyfault5, R Scott Rector6.   

Abstract

Exercise stimulates hepatic mitochondrial adaptations; however, the mechanisms remain largely unknown. Here we tested whether FGF21 plays an obligatory role in exercise induced hepatic mitochondrial adaptations by testing exercise responses in FGF21 knockout mice. FGF21 knockout (FGF21-KO) and wild-type (WT) mice (11-12 wk of age) had access to voluntary running wheels for exercise (EX) or remained sedentary for 8 wk. FGF21 deficiency resulted in greater body weight, adiposity, serum cholesterol, insulin, and glucose concentrations compared with WT mice (P < 0.05). In addition, hepatic mitochondrial complete palmitate oxidation, β-hydroxyacyl-CoA dehydrogenase (β-HAD) activity, and nuclear content of PGC-1α were 30-50% lower in FGF21-KO mice compared with WT mice (P < 0.01). EX effectively lowered body weight, adiposity, serum triglycerides, free fatty acids, and insulin and normalized mitochondrial complete palmitate oxidation in the FGF21-KO mice, whereas the reduced hepatic β-HAD activity and lowered nuclear content of PGC-1α in FGF21-KO mice were not restored by EX. In addition, EX increased hepatic CPT-1α mRNA expression and ACC phosphorylation (a marker of increased AMPK activity) and reduced hepatic triacylglycerol content in both genotypes. However, FGF21-KO mice displayed a lower EX-induced increase in the mRNA expression of the hepatic gluconeogenic gene, PEPCK, compared with WT. In conclusion, FGF21 does not appear necessary for exercise-induced systemic and hepatic mitochondrial adaptations, but the increased adiposity, hyperinsulinemia, and impairments in hepatic mitochondrial function induced by FGF21 deficiency can be partially rescued by daily wheel running exercise.

Entities:  

Keywords:  exercise; metabolism; mitochondria; mitochondrial function

Mesh:

Substances:

Year:  2016        PMID: 27012775      PMCID: PMC4895870          DOI: 10.1152/ajpgi.00355.2015

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  45 in total

1.  Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver.

Authors:  Tobias Nørresø Haase; Stine Ringholm; Lotte Leick; Rasmus Sjørup Biensø; Kristian Kiilerich; Sune Johansen; Maja Munk Nielsen; Jørgen Fp Wojtaszewski; Juan Hidalgo; Per Amstrup Pedersen; Henriette Pilegaard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

2.  Cessation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue.

Authors:  Matthew J Laye; R Scott Rector; Sarah J Borengasser; Scott P Naples; Grace M Uptergrove; Jamal A Ibdah; Frank W Booth; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2008-10-30

3.  Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model.

Authors:  R Scott Rector; Grace M Uptergrove; E Matthew Morris; Sarah J Borengasser; M Harold Laughlin; Frank W Booth; John P Thyfault; Jamal A Ibdah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

4.  Changes in skeletal muscle mitochondria in response to the development of type 2 diabetes or prevention by daily wheel running in hyperphagic OLETF rats.

Authors:  R Scott Rector; Grace M Uptergrove; Sarah J Borengasser; Catherine R Mikus; E Matthew Morris; Scott P Naples; Matthew J Laye; M Harold Laughlin; Frank W Booth; Jamal A Ibdah; John P Thyfault
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-16       Impact factor: 4.310

5.  Modulating fibroblast growth factor 21 in hyperphagic OLETF rats with daily exercise and caloric restriction.

Authors:  Justin A Fletcher; Grace M Meers; M Harold Laughlin; Jamal A Ibdah; John P Thyfault; R Scott Rector
Journal:  Appl Physiol Nutr Metab       Date:  2012-08-15       Impact factor: 2.665

6.  Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.

Authors:  Ffolliott M Fisher; Patricia C Chui; Imad A Nasser; Yury Popov; Jeremy C Cunniff; Thomas Lundasen; Alexei Kharitonenkov; Detlef Schuppan; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Gastroenterology       Date:  2014-07-30       Impact factor: 22.682

7.  The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

Authors:  Cecilia Gälman; Tomas Lundåsen; Alexei Kharitonenkov; Holly A Bina; Mats Eriksson; Ingiäld Hafström; Maria Dahlin; Per Amark; Bo Angelin; Mats Rudling
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

8.  Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats.

Authors:  R Scott Rector; John P Thyfault; R Tyler Morris; Matthew J Laye; Sarah J Borengasser; Frank W Booth; Jamal A Ibdah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-03       Impact factor: 4.052

9.  Increased responses to the actions of fibroblast growth factor 21 on energy balance and body weight in a seasonal model of adiposity.

Authors:  M Murphy; R Samms; A Warner; M Bolborea; P Barrett; M J Fowler; J M Brameld; K Tsintzas; A Kharitonenkov; A C Adams; T Coskun; F J P Ebling
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

10.  Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans.

Authors:  Jakob Schiøler Hansen; Jens Otto Clemmesen; Niels Henry Secher; Miriam Hoene; Andrea Drescher; Cora Weigert; Bente Klarlund Pedersen; Peter Plomgaard
Journal:  Mol Metab       Date:  2015-06-12       Impact factor: 7.422

View more
  8 in total

1.  Hepatocyte-specific eNOS deletion impairs exercise-induced adaptations in hepatic mitochondrial function and autophagy.

Authors:  Rory P Cunningham; Mary P Moore; Ryan J Dashek; Grace M Meers; Vivien Jepkemoi; Takamune Takahashi; Victoria J Vieira-Potter; Jill A Kanaley; Frank W Booth; R Scott Rector
Journal:  Obesity (Silver Spring)       Date:  2022-03-31       Impact factor: 9.298

2.  Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.

Authors:  Justin A Fletcher; Melissa A Linden; Ryan D Sheldon; Grace M Meers; E Matthew Morris; Anthony Butterfield; James W Perfield; R Scott Rector; John P Thyfault
Journal:  Exp Physiol       Date:  2018-01-16       Impact factor: 2.969

3.  Anti-inflammatory effects of exercise training in adipose tissue do not require FGF21.

Authors:  Jay W Porter; Joe L Rowles; Justin A Fletcher; Terese M Zidon; Nathan C Winn; Leighton T McCabe; Young-Min Park; James W Perfield; John P Thyfault; R Scott Rector; Jaume Padilla; Victoria J Vieira-Potter
Journal:  J Endocrinol       Date:  2017-08-01       Impact factor: 4.286

4.  Pros and cons of insulin administration on liver glucose metabolism in strength-trained healthy mice.

Authors:  V A R Pereira; K S Vedovelli; G Y Muller; Y F Depieri; D H C G Avelar; A H E de Amo; D R Jimenes; J N L Martins; A C Silvério; C R G Gomes; V A F Godoi; M M D Pedrosa
Journal:  Braz J Med Biol Res       Date:  2019-01-24       Impact factor: 2.590

Review 5.  Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease.

Authors:  Jelena Stevanović; Jorge Beleza; Pedro Coxito; António Ascensão; José Magalhães
Journal:  Mol Metab       Date:  2019-11-29       Impact factor: 7.422

Review 6.  FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.

Authors:  Emma Henriksson; Birgitte Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-22       Impact factor: 5.555

Review 7.  Hepatokines as a Molecular Transducer of Exercise.

Authors:  Dae Yun Seo; Se Hwan Park; Jubert Marquez; Hyo-Bum Kwak; Tae Nyun Kim; Jun Hyun Bae; Jin-Ho Koh; Jin Han
Journal:  J Clin Med       Date:  2021-01-20       Impact factor: 4.241

Review 8.  Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms.

Authors:  Hirokazu Takahashi; Kazuhiko Kotani; Kenichi Tanaka; Yuichiro Egucih; Keizo Anzai
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-15       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.